Physician profile
Paul Lanier
NPI 1982969846
$3,515.57
in general payments reported to CMS, 2019-2025
13 companies · $578 in 2025
The $578 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $472 · 2022: $2,089 · 2023: $284 · 2024: $92.78 · 2025: $578.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $843 · Travel and Lodging: $112.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $843.17 |
| Travel and Lodging | $111.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Empire Medical, INC | $1,810.54 | 2022 | |
| Si-Bone, INC. | $435.95 | 2023-2025 | |
| Stryker Corporation | $378.79 | 2019 | |
| Arthrex, INC. | $278.08 | 2022 | |
| Globus Medical, INC. | $245.41 | 2024-2025 | Xlif, Hedron Ia, Excelsius Deformity |
| Alphatec Spine, INC | $103.37 | 2025 | Lif, Other - Miscellaneous, Identiti |
| Spr Therapeutics, INC | $93.00 | 2025 | Sprint Pns System |
| Smith+Nephew, INC. | $43.12 | 2019 | |
| Xtant Medical INC | $42.01 | 2025 | |
| Djo, LLC | $33.33 | 2019 | |
| Abbott Laboratories | $18.43 | 2025 | Proclaim |
| Pacira Pharmaceuticals Incorporated | $16.82 | 2019 | |
| Biocomposites INC | $16.72 | 2025 | Stimulan |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Lanier listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.